Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients.


Journal

JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004

Informations de publication

Date de publication:
23 03 2020
Historique:
received: 05 08 2019
revised: 23 12 2019
accepted: 02 01 2020
entrez: 21 3 2020
pubmed: 21 3 2020
medline: 21 10 2020
Statut: ppublish

Résumé

The aim of this study was to evaluate the feasibility of coronary access and aortic valve reintervention in low-risk patients undergoing transcatheter aortic valve replacement (TAVR) with a balloon-expandable transcatheter heart valve (THV). Younger, low-risk TAVR patients are more likely than older, higher risk patients to require coronary angiography, percutaneous coronary intervention, or aortic valve reintervention, but their THVs may impede coronary access and cause coronary obstruction during TAVR-in-TAVR. The LRT (Low Risk TAVR) trial (NCT02628899) enrolled 200 subjects with symptomatic severe aortic stenosis to undergo TAVR using commercially available THVs. Subjects who received balloon-expandable THVs and who had 30-day cardiac computed tomographic scans were included in this study. In a subgroup, the feasibility of intentional THV crimping on the delivery catheter to pre-determine commissural alignment was tested. In the LRT trial, 168 subjects received balloon-expandable THVs and had 30-day cardiac computed tomographic scans, of which 137 were of adequate image quality for analysis. The most challenging anatomy for coronary access (THV frame above and commissural suture post in front of a coronary ostium) was observed in 9% to 13% of subjects. Intentional THV crimping did not appear to meaningfully affect commissural alignment. The THV frame extended above the sinotubular junction in 21% of subjects, and in 13%, the distance between the THV and the sinotubular junction was <2 mm, signifying that TAVR-in-TAVR may not be feasible without causing coronary obstruction. TAVR may present challenges to future coronary access and aortic valve reintervention in a substantial number of low-risk patients.

Sections du résumé

OBJECTIVES
The aim of this study was to evaluate the feasibility of coronary access and aortic valve reintervention in low-risk patients undergoing transcatheter aortic valve replacement (TAVR) with a balloon-expandable transcatheter heart valve (THV).
BACKGROUND
Younger, low-risk TAVR patients are more likely than older, higher risk patients to require coronary angiography, percutaneous coronary intervention, or aortic valve reintervention, but their THVs may impede coronary access and cause coronary obstruction during TAVR-in-TAVR.
METHODS
The LRT (Low Risk TAVR) trial (NCT02628899) enrolled 200 subjects with symptomatic severe aortic stenosis to undergo TAVR using commercially available THVs. Subjects who received balloon-expandable THVs and who had 30-day cardiac computed tomographic scans were included in this study. In a subgroup, the feasibility of intentional THV crimping on the delivery catheter to pre-determine commissural alignment was tested.
RESULTS
In the LRT trial, 168 subjects received balloon-expandable THVs and had 30-day cardiac computed tomographic scans, of which 137 were of adequate image quality for analysis. The most challenging anatomy for coronary access (THV frame above and commissural suture post in front of a coronary ostium) was observed in 9% to 13% of subjects. Intentional THV crimping did not appear to meaningfully affect commissural alignment. The THV frame extended above the sinotubular junction in 21% of subjects, and in 13%, the distance between the THV and the sinotubular junction was <2 mm, signifying that TAVR-in-TAVR may not be feasible without causing coronary obstruction.
CONCLUSIONS
TAVR may present challenges to future coronary access and aortic valve reintervention in a substantial number of low-risk patients.

Identifiants

pubmed: 32192693
pii: S1936-8798(20)30268-5
doi: 10.1016/j.jcin.2020.01.202
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

726-735

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Auteurs

Toby Rogers (T)

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC; Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Benjamin C Greenspun (BC)

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.

Gaby Weissman (G)

Department of Cardiology, MedStar Washington Hospital Center, Washington, DC.

Rebecca Torguson (R)

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.

Paige Craig (P)

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.

Christian Shults (C)

Division of Cardiothoracic Surgery, MedStar Washington Hospital Center, Washington, DC.

Paul Gordon (P)

Division of Cardiology, The Miriam Hospital, Providence, Rhode Island.

Afshin Ehsan (A)

Division of Cardiothoracic Surgery, Lifespan Cardiovascular Institute, Providence, Rhode Island.

Sean R Wilson (SR)

Department of Medicine, The Valley Hospital, Ridgewood, New Jersey.

John Goncalves (J)

Cardiac Surgery Program, The Valley Hospital, Ridgewood, New Jersey.

Robert Levitt (R)

Department of Cardiology, Henrico Doctors' Hospital, Richmond, Virginia.

Chiwon Hahn (C)

Department of Cardiothoracic Surgery, Henrico Doctors' Hospital, Richmond, Virginia.

Puja Parikh (P)

Department of Medicine, Stony Brook Hospital, Stony Brook, New York.

Thomas Bilfinger (T)

Department of Surgery, Stony Brook Hospital, Stony Brook, New York.

David Butzel (D)

Cardiovascular Service Line, Maine Medical Center, Portland, Maine.

Scott Buchanan (S)

Cardiovascular Service Line, Maine Medical Center, Portland, Maine.

Nicholas Hanna (N)

St. John Heart Institute Cardiovascular Consultants, St. John Health System, Tulsa, Oklahoma.

Robert Garrett (R)

St. John Clinic Cardiovascular Surgery, St. John Heart Institute Cardiovascular Consultants, St. John Health System, Tulsa, Oklahoma.

Maurice Buchbinder (M)

Foundation for Cardiovascular Medicine, Stanford University, Stanford, California.

Federico Asch (F)

MedStar Health Research Institute, MedStar Washington Hospital Center, Washington, DC.

Hector M Garcia-Garcia (HM)

MedStar Health Research Institute, MedStar Washington Hospital Center, Washington, DC.

Petros Okubagzi (P)

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.

Itsik Ben-Dor (I)

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.

Lowell F Satler (LF)

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.

Ron Waksman (R)

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC. Electronic address: ron.waksman@medstar.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH